---
figid: PMC2564853__nihms66580f1
figtitle: BRCA-FA pathway as a target for anti-tumor drugs
organisms:
- Homo sapiens
organisms_ner:
- Arabidopsis thaliana
pmcid: PMC2564853
filename: nihms66580f1.jpg
figlink: /pmc/articles/PMC2564853/figure/F1/
number: F1
caption: Activation of the pathway is required to mediate the DNA damage response,
  repair, and checkpoint response to maintain genomic stability. Loss or inactivation
  of this pathway leads to defects in DNA repair and/or checkpoint responses that
  reduce cell survival following ICL-treatment.
papertitle: BRCA-FA pathway as a target for anti-tumor drugs.
reftext: Rachel Litman, et al. Anticancer Agents Med Chem. ;8(4):426-430.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8958416
figid_alias: PMC2564853__F1
figtype: Figure
redirect_from: /figures/PMC2564853__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2564853__nihms66580f1.html
  '@type': Dataset
  description: Activation of the pathway is required to mediate the DNA damage response,
    repair, and checkpoint response to maintain genomic stability. Loss or inactivation
    of this pathway leads to defects in DNA repair and/or checkpoint responses that
    reduce cell survival following ICL-treatment.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ICL
  - LATE
  - BRCA1
---
